申请人:LY Tai Wei
公开号:US20110230487A1
公开(公告)日:2011-09-22
Provided herein are arylsulfonamides that are useful for modulating CCR3 activity, and pharmaceutical compositions thereof. Also provided herein are methods of their use for treating, preventing, or ameliorating one or more symptoms of a CCR3-mediated disorder, disease, or condition.
本文提供了对芳基磺酰胺的使用,用于调节CCR3活性,以及其药物组合物。本文还提供了它们的使用方法,用于治疗、预防或改善CCR3介导的疾病、疾病或症状之一。